Magnerot

Magnesium Orotate Dihydrate, the active ingredient in Magnerot, is a magnesium supplement presented as an oral dosage form for oral use. It is used to address magnesium deficiency, alleviate muscle cramps, and support normal cardiovascular function in adults.

GNH USA supplies Magnerot as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Magnerot is a magnesium supplement that acts on electrolyte balance and cellular energy pathways. - Magnesium deficiency: helps restore normal magnesium concentrations in body tissues. - Muscle cramps: may reduce the frequency and intensity of involuntary muscle contractions. - Cardiovascular support: contributes to the maintenance of normal heart rhythm and vascular tone.

Magnesium Orotate Dihydrate is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Diarrhea: loose stools occurring after oral intake. - Nausea: feeling of stomach discomfort or urge to vomit. - Abdominal cramping: mild to moderate stomach pain. - Flatulence: increased gas production in the gastrointestinal tract. - Headache: transient mild headache.

Serious or Rare Side Effects: - Hypermagnesemia: elevated blood magnesium levels, potentially causing cardiac arrhythmia. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Muscle weakness: unusual loss of strength or fatigue.

When using Magnerot, consider the following safety measures. - Renal impairment: assess kidney function before initiating therapy. - Concomitant medications: review other drugs that affect magnesium balance. - Pregnancy and lactation: use only if clearly needed and prescribed. - Elderly patients: start with the lowest effective dose and monitor. - Storage: Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Magnerot may interact with certain medicines, requiring attention to dosage and monitoring.

Major Interactions (Avoid): - Calcium channel blockers: may potentiate hypotensive effects. - Certain antibiotics (e.g., tetracyclines, quinolones): reduced absorption of the antibiotic.

Moderate Interactions (Monitor Closely): - Diuretics (loop or thiazide): increased risk of electrolyte imbalance. - Bisphosphonates: decreased absorption of the bone‑protective agent. - Proton pump inhibitors: possible alteration of magnesium status.